Arbor Biotechnologies Funding & Investors
Cambridge, MA
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
arbor.bioTotal Amount Raised: $304,500,000
Arbor Biotechnologies Funding Rounds
Series C
$73,900,000
Series C Investors
Arch Venture PartnersTCG Crossover ManagementRevelation PartnersPartners InvestmentQatar Investment AuthorityAlly Bridge GroupArrowMark Colorado HoldingsDeep Track CapitalTemasekT. Rowe PriceSurveyor CapitalVertex PharmaceuticalsPiper Heartland Healthcare CapitalAberdeenKerna VenturesSeries B
$215,000,000
Series B Investors
Ally Bridge GroupTCG Crossover ManagementTemasekS32Woodline PartnersRidgeback Capital ManagementGreatPoint VenturesT. Rowe PriceHenderson Global InvestorsIllumina VenturesOno Venture InvestmentVertex PharmaceuticalsDeep Track CapitalSurveyor CapitalTekla Capital ManagementArch Venture PartnersTao Capital PartnersLogos CapitalArrowMark Colorado HoldingsSeries A
$15,600,000
Series A Investors
Arch Venture PartnersAlexandria Real Estate Equities
Funding info provided by Diffbot.